The U.S. Food and Drug Administration (FDA) is tasked with regulating the tens of thousands prescription and over-the-counter drugs we consume each year. Unfortunately, drug manufacturers illegally markets its drug for uses outside its approved use in an attempt to boost sales and pad the bottom line. Such is the […]
Let’s face it: whistleblowers do not embark on the qui tam lawsuit labyrinth expecting the experience to be without conflict. Earlier this summer, a former employee of ITT Educational Services, Inc. commenced a lawsuit against the for-profit nationwide university under the qui tam provisions of the False Claims Act in […]
Earlier, we introduced you to some record-breaking qui tam lawsuits exposing rampant waste of taxpayer money and resources by healthcare providers. Nearly every entry on the list pertained to healthcare fraud, and this second entry in the two-part series is certainly no exception. As we continue to explore some of […]
Those of us working closely on whistleblower cases are always thrilled to hear statistics revealing the true gravity and importance of qui tam cases. For instance, the Department of Justice reports that in 2012 alone, over $439 million was awarded to qui tam whistleblowers, individuals who brought lawsuits on behalf […]
The False Claims Act is designed to protect American taxpayers from fraud, waste and abuse by those holding contracts with the United States government. Known as whistleblowers, these individuals stand to gain a sizable portion of any recovery obtained by the government – usually between 15 and 25 percent of […]